HERMES: Delivery of a Speedy Prostate Cancer Treatment.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial.BMJ open · 2026
   Article
2. Simulation-free radiotherapy on the MR-linac in prostate cancer.The British journal of radiology · 2025
   Article
3. Towards clinical implementation of T2-weighted cine imaging for intrafraction drift correction workflows on the 1.5 Tesla magnetic resonance-linear accelerator.Physics and imaging in radiation oncology · 2025
   Article
4. Cost-Outcome of Radiotherapy for Local Control and Overall Survival Outcomes for Selected Cancers.Journal of medical imaging and radiation oncology · 2025
   Article
5. MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study.Clinical and translational radiation oncology · 2024
   Article
6. Treatment planning evaluation and experimental validation of the magnetic resonance-based intrafraction drift correction.Physics and imaging in radiation oncology · 2024
   Article
7. The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus?World journal of urology · 2023
   Review
8. Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.Physics and imaging in radiation oncology · 2022
   Article
9. Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology.Frontiers in oncology · 2022
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as